The Hims & Hers release comes amid a shortage of GLP-1s, as the demand for medications to treat obesity and diabetes outpaces the supply
Well tailor your injection to your individual needs
It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine
Neither the author nor the publisher assumes liability for the use, interpretation, or implementation of the information contained within this article across third-party platforms
GLP-1 is meant to support a broader weight loss program
Offering their weight-loss and diabetes medications directly to patients, similar to how the compounding companies were operating, is a marked departure from the norm and could have profound effects for patients, plan sponsors, and the broader healthcare system